据《华盛顿邮报》的报道,首个用埃博拉幸存者的血液来治疗埃博拉患者的临床试验在西非拉开序幕,其目的是测试埃博拉幸存者向患者捐献的血浆或血液是否安全、有效,并能够减少疾病和死亡。采取这一疗法的理论依据是:幸存者体内的血液里可能已经存在埃博拉病毒的抗体,能够有效地对抗埃博拉病毒。以血为药的古老理念用幸存者的血液治疗患有同 According to the Washington Post, the first clinical trial to treat Ebola patients with blood from Ebola survivors kicked off in West Africa with the aim of testing plasma or blood donated by Ebola survivors to patients Safe, effective and able to reduce illness and death. The rationale for taking this therapy is that the Ebola virus may already be present in the bloodstream of the survivors, effectively fighting the Ebola virus. The ancient idea of ​​blood medicine uses the same blood as survivors